Menu
Back to Systems Implementation
04/01/26

Blood culture contamination and subsequent unnecessary health care utilization in pediatrics.

Childress, Kelsey; Hartmann, Michael; Kwan, Marilyn L; Cooch, Peter. Hosp Pediatr.

Collection Topics
Business Case for Excellence Tests, Screening, and Laboratory Processes
Share

Most recent

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group.

Turbett, Daragiati, T. Chu, et al., Antimicrob Steward Healthc Epidemiol.
09/01/26 Business Case for Excellence Tests, Screening, and Laboratory Processes

Diagnosing in the dark: the childbirth-related post-traumatic stress disorder GP evidence gap.

Foreman, Hillman, Cross, et al., Br J Gen Pract.
09/01/26 Culture, Work System, and Implementation Equity, Access, and Timeliness Tests, Screening, and Laboratory Processes

Learning and deskilling effects of artificial intelligence in colonoscopy among endoscopists with different levels of experience: a pragmatic, prospective trial.

Pedersen, Mori, Botteri, et al., Endoscopy.
09/01/26 AI and Diagnosis Cognition and Decision Making Tests, Screening, and Laboratory Processes

Summary

Contaminated blood cultures drive billions in annual US healthcare costs, but the pediatric burden is understudied. The results of this retrospective cohort study across outpatient, inpatient, and hospital settings find that contamination was linked to more emergency department visits, admissions, and longer stays, increasing costs and patient impact particularly in the outpatient setting.
Read the paper
Childress K, Hartmann M, Kwan ML, et al. Blood culture contamination and subsequent unnecessary health care utilization in pediatrics. Hosp Pediatr. 2026;16(4):331-338.